These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 24523438)

  • 1. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.
    Di Caro G; Bergomas F; Grizzi F; Doni A; Bianchi P; Malesci A; Laghi L; Allavena P; Mantovani A; Marchesi F
    Clin Cancer Res; 2014 Apr; 20(8):2147-58. PubMed ID: 24523438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical utility of the local inflammatory response in colorectal cancer.
    Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
    Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
    Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
    Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
    Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Low Densities of FoxP3
    Cavalleri T; Bianchi P; Basso G; Celesti G; Grizzi F; Bossi P; Greco L; Pitrone C; Valtorta E; Mauri G; Truini M; Dall'Olio FG; Brandi G; Sartore-Bianchi A; Ricciardiello L; Torri V; Rimassa L; Siena S; Mantovani A; Malesci A; Laghi L;
    Cancer Immunol Res; 2019 May; 7(5):751-758. PubMed ID: 30804005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma.
    Mao Y; Sun J; Wang WP; Zhang XG; Hua D
    Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.
    Huh JW; Lee JH; Kim HR
    Arch Surg; 2012 Apr; 147(4):366-72. PubMed ID: 22508783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
    Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
    Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
    Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.
    Koch M; Beckhove P; Op den Winkel J; Autenrieth D; Wagner P; Nummer D; Specht S; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Weitz J
    Ann Surg; 2006 Dec; 244(6):986-92; discussion 992-3. PubMed ID: 17122624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.
    Correale P; Rotundo MS; Botta C; Del Vecchio MT; Ginanneschi C; Licchetta A; Conca R; Apollinari S; De Luca F; Tassone P; Tagliaferri P
    Clin Cancer Res; 2012 Feb; 18(3):850-7. PubMed ID: 22142823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
    Mlecnik B; Tosolini M; Kirilovsky A; Berger A; Bindea G; Meatchi T; Bruneval P; Trajanoski Z; Fridman WH; Pagès F; Galon J
    J Clin Oncol; 2011 Feb; 29(6):610-8. PubMed ID: 21245428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Front Immunol; 2018; 9():2354. PubMed ID: 30369930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.
    Allard MA; Bachet JB; Beauchet A; Julie C; Malafosse R; Penna C; Nordlinger B; Emile JF
    Diagn Pathol; 2012 Nov; 7():156. PubMed ID: 23148481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.